Lipid Digestion & Transport

Pancreatic lipase acts at a fat-water interface, releasing fatty acids and monoacylglycerols from triacylglycerol. Colipase helps the enzyme work at an interface in the presence of bile salts. Emulsification improves access; it is not itself cleavage of a chemical bond.

Bile-salt-rich mixed micelles can carry poorly water-soluble digestion products through the watery environment near the brush border. The products transfer to the epithelial surface. A mixed micelle is not a complete package that normally travels intact through the cell into lymph.

The epithelial membrane is a separate boundary. Diffusion and protein-associated processes contribute to uptake, with their importance depending on substrate and conditions. Naming CD36 or another protein does not establish a universal exclusive entry gate.

Within an enterocyte, long-chain fatty acids are activated and used with monoacylglycerol to rebuild triacylglycerol. MGAT and DGAT contribute successive acyl-transfer reactions. This intracellular synthesis is distinct from the luminal lipase reactions that first made the uptake products.

The endoplasmic reticulum supports lipid synthesis and early lipoprotein assembly. Not every entering fatty acid is immediately secreted: some lipid enters cytoplasmic storage pools or is used by the cell. An absorbed amount and a simultaneously secreted amount need not be identical.

Intestinal apoB48 associates with lipids during early assembly in the ER. Microsomal triglyceride transfer protein, commonly called MTP and encoded by MTTP, supports lipidation. A growing neutral-lipid core and an amphipathic surface create a particle that can travel in an aqueous extracellular environment.

A chylomicron has a surface phospholipid monolayer with associated proteins and free cholesterol around a neutral-lipid-rich core. This differs from the phospholipid bilayer surrounding a transport vesicle. The particle is not a hollow cell with an aqueous cytoplasm.

Human intestinal apoB48 and hepatic apoB100 are related forms produced from the same gene through different RNA processing. This does not make an intestinal chylomicron the same as a liver-secreted VLDL particle. Mouse editing experiments illuminate function without establishing a universal human particle output.

Developing particles move from the ER toward the Golgi in specialised transport carriers. Further processing precedes transfer toward the basolateral membrane. Fusion of a secretory carrier with that membrane releases its contents into the tissue-facing space.

Basolateral release does not mean a particle has already entered a lymphatic lumen. The lamina propria and the lacteal wall remain between the enterocyte and flowing lymph. Particle assembly, epithelial exit and lymphatic transport can each influence the timing of delivery.

After entering lacteals, particles travel through intestinal lymphatic pathways and larger lymphatic conduits. Thoracic-duct drainage returns this lymph to venous blood. This supplies the systemic circulation before the later hepatic handling of remnants.

Bile-acid recovery follows a different loop: intestinal reabsorption and portal return to the liver. The bile components helping luminal lipid delivery do not simply remain attached to every chylomicron for the entire lymphatic journey.

Lipoprotein lipase (LPL) acts at the blood-facing capillary interface to hydrolyse triacylglycerol carried by particles. Released fatty acids can support tissue uptake, use or storage. This is downstream of digestion in the intestinal lumen; the two lipases should not be drawn as one enzyme moving along with the food.

As lipid is removed and particle composition changes, remnants can be cleared by the liver. The body does not need to push every whole chylomicron directly inside a muscle cell before its fatty acids become available.

Chylomicrons are important but do not account for every intestinal lipid route. Cholesterol and some other lipid classes also participate in pathways involving different transport systems and lipoproteins. A selected long-chain triacylglycerol lesson must not become an all-lipid exclusivity claim.